C
CSWYF
vs
S&P 500
S&P 500
Over the past 12 months, CSWYF has underperformed S&P 500, delivering a return of 0% compared to the S&P 500's +17% growth.
Stocks Performance
CSWYF vs S&P 500
Performance Gap
CSWYF vs S&P 500
Performance By Year
CSWYF vs S&P 500
Compare the stock's returns with its benchmark index and competitors. Gain insights into its relative performance over time.
China Shineway Pharmaceutical Group Ltd
Glance View
In the bustling world of pharmaceuticals, China Shineway Pharmaceutical Group Ltd. stands as a noteworthy player adeptly navigating the intricate channels of traditional Chinese medicine and modern pharmaceutical practices. Established in 1996, the company has rooted its foundation in the age-old wisdom of Chinese herbal medicine, while seamlessly integrating contemporary manufacturing methods. Headquartered in the industrial city of Shijiazhuang, Shineway has grown into one of China's top pharmaceutical enterprises, distinguished by its commitment to quality and innovation in healthcare solutions. At the heart of Shineway's operations is a robust production line that focuses on the development and distribution of herbal-based medicines, granules, and injections that cater to a diverse array of health needs, ranging from respiratory ailments to cardiovascular conditions. Shineway's journey to profitability hinges on a well-crafted strategy of combining the trusted efficacy of traditional Chinese cures with rigorous scientific validation and modern production processes. With a comprehensive distribution network spanning domestic markets and cautiously expanding international borders, the company has managed to effectively channel its products through hospitals, clinics, and retail pharmacies. Their financial success is further bolstered by substantial investments in technology and research, allowing Shineway to continuously refine its offerings and maintain competitive prices. In an era where the global health landscape is constantly evolving, China Shineway Pharmaceutical Group Ltd. thrives by striking a delicate balance between preserving traditional medicinal heritage and embracing the advancements of contemporary pharmaceutical sciences, thereby securing a steady revenue stream while fostering broader acceptance of traditional Chinese medicine across the globe.
